204 related articles for article (PubMed ID: 33297908)
1. Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides.
Sánchez-López E; Gómara MJ; Haro I
Curr Med Chem; 2021; 28(22):4356-4379. PubMed ID: 33297908
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
3. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
4. The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
Ferguson LM; Rohan LC
Ther Deliv; 2011 Dec; 2(12):1535-50. PubMed ID: 22468220
[TBL] [Abstract][Full Text] [Related]
5. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
6. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
7. Vaginal microbicides and their delivery platforms.
D'Cruz OJ; Uckun FM
Expert Opin Drug Deliv; 2014 May; 11(5):723-40. PubMed ID: 24506783
[TBL] [Abstract][Full Text] [Related]
8. Topical microbicides for preventing sexually transmitted infections.
Obiero J; Ogongo P; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007961. PubMed ID: 33719075
[TBL] [Abstract][Full Text] [Related]
9. Twice-daily application of HIV microbicides alter the vaginal microbiota.
Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
[TBL] [Abstract][Full Text] [Related]
10. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
11. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
12. Application of nanotechnology for the development of microbicides.
Brako F; Mahalingam S; Rami-Abraham B; Craig DQ; Edirisinghe M
Nanotechnology; 2017 Feb; 28(5):052001. PubMed ID: 28032619
[TBL] [Abstract][Full Text] [Related]
13. Topical microbicides for prevention of sexually transmitted infections.
Obiero J; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
[TBL] [Abstract][Full Text] [Related]
14. Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides.
Fetherston SM; Malcolm RK; Woolfson AD
Ther Deliv; 2010 Dec; 1(6):785-802. PubMed ID: 22834014
[TBL] [Abstract][Full Text] [Related]
15. Advances in microbicide vaginal rings.
Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
[TBL] [Abstract][Full Text] [Related]
16. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD
Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111
[TBL] [Abstract][Full Text] [Related]
17. Recent advances on anti-HIV vaginal delivery systems development.
Antimisiaris SG; Mourtas S
Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves J; Amiji M; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
[TBL] [Abstract][Full Text] [Related]
19. Nano-sized platforms for vaginal drug delivery.
El-Hammadi MM; Arias JL
Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine in the development of anti-HIV microbicides.
das Neves J; Nunes R; Rodrigues F; Sarmento B
Adv Drug Deliv Rev; 2016 Aug; 103():57-75. PubMed ID: 26829288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
